Novo Nordisk A S NVO Cash Flow Statement (2012-2016)

NYSE NVO
$46.18 -0.29 (-0.62%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016
Operating Activities
Net Income (Quarter) 1,068.00M1,199.00M1,239.00M1,295.00M1,375.00M1,523.00M1,473.00M1,422.00M1,185.00M1,286.00M1,153.00M1,090.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M
Cash from Operations (Quarter) 985.00M1,237.00M1,343.00M270.00M1,251.00M1,277.00M1,105.00M986.00M747.00M1,493.00M2,191.00M1,211.00M620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M
Cash from Discontinued Operations (Quarter) 985.00M1,237.00M1,343.00M270.00M1,251.00M1,277.00M1,105.00M986.00M747.00M1,493.00M2,191.00M1,211.00M620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 112.00M114.00M108.00M131.00M122.00M119.00M114.00M143.00M121.00M122.00M212.00M156.00M100.00M96.00M94.00M150.00M92.00M109.00M
Investing Activities
Capital Expenditures (Quarter) 91.00M148.00M159.00M175.00M138.00M137.00M161.00M135.00M127.00M148.00M176.00M259.00M115.00M151.00M186.00M322.00M161.00M254.00M
Divestments (Quarter) 359.00M
Additional items
Free Cash Flow (Quarter) -91.00M-148.00M-159.00M-175.00M-138.00M-137.00M-161.00M-135.00M-127.00M-148.00M-176.00M-259.00M-115.00M-151.00M-186.00M-322.00M-161.00M-254.00M
Change in Cash (Quarter) 1,085.00M1,168.00M78.00M1,094.00M1,126.00M927.00M834.00M601.00M1,332.00M2,005.00M939.00M853.00M1,609.00M1,611.00M1,014.00M939.00M1,920.00M
Net Cash Flow (Quarter) 985.00M1,237.00M1,343.00M270.00M1,251.00M1,277.00M1,105.00M986.00M747.00M1,493.00M2,191.00M1,211.00M620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M